News
Was Celgene’s Third Quarter Really Crash-Worthy?
On the heels of reporting a disappointing late-stage trial failure, Celgene Corp. (NASDAQ: CELG) issued a poor third-quarter financial report that's stoking investors' fears. Has the biotech lost....
Abiomed, Inc's Revenue and Profits Soar Yet Again
Abiomed (NASDAQ: ABMD), a medical-device maker focused on minimally invasive heart pumps, reported its fiscal second-quarter earnings on Thursday, Oct. 26. The company once again reported strong....
Should You Be Worried After Bristol-Myers Squibb's Q3 Results?
It's been an up-and-down kind of year for Bristol-Myers Squibb (NYSE: BMY). Early in 2017, investors were concerned after the company opted not to pursue accelerated approval for a combination of....
3 Dividend Stocks Perfect for Retirement
Retirement is a time to shift one's investment portfolio to a more defensive posture. If this can be done while generating income via dividend payouts, so much the better. We asked three of our....
Why Celgene Corporation Tumbled Today
Celgene (NASDAQ: CELG) is down 18.2% at 12:11 p.m. Thursday after releasing third-quarter earnings. It wasn't so much third-quarter revenue, which was up 10% year over year, or the adjusted....
Here's Why Idera Pharmaceuticals Plunged as Much as 35% Today
Shares of pre-revenue biopharma Idera Pharmaceuticals (NASDAQ: IDRA) sank as much as 35% this morning after the company announced the pricing of a major public stock offering. The company will....
3 Value Stocks for Smart Investors
Everyone loves a good bargain, whether it be at the local store or, for smart investors, on Wall Street. And though we are well into a secular bull market that has lasted practically since the....
5 Intriguing Things Illumina's Management Said in Its Q3 Update
"Let the good times roll" might be a good theme for Illumina (NASDAQ: ILMN) in 2017. The gene-sequencing pioneer reported its third-quarter results on Tuesday. Illumina once again beat....
5 Things You'll Want to Watch With AbbVie's Q3 Results
If 2017 ended right now, it would go down as AbbVie's (NYSE: ABBV) best ever. The biotech stock's price has risen a little more than the 50% gains AbbVie made during its first year as a....
Price Hikes Insulate Celgene From a Failure
After independent monitors concluded a phase 3 trial of GED-301 in Crohn's disease was a failure, Celgene (NASDAQ: CELG) shelved its plans to develop this drug for use in that billion-dollar....
What's Behind Amgen's Q3 Revenue Decline
When Amgen (NASDAQ: AMGN) announced its second-quarter results in July, the anemic revenue growth was overshadowed by the company's solid earnings increase and its improved full-year guidance. CEO....
Why MacroGenics, Inc. Stock Soared Today
Shares of the clinical-stage oncology and autoimmune disease specialist MacroGenics (NASDAQ: MGNX) ended the day higher by a healthy 17.36% on a whopping 17.5 times the average volume.The....
Biogen Inc Content With "Resilience" of Its Multiple Sclerosis Franchise
Biogen (NASDAQ: BIIB) grew earnings faster than revenue in the third quarter, which is what investors should be looking for from any mature company in their portfolio. Nevertheless, shares went....
Baxter International Inc.'s Cost-Cutting Efforts Pay Off in the Third Quarter
When Baxter International (NYSE: BAX) reported quarterly results in July, there was a stark contrast between the company's top and bottom lines. Revenue growth was essentially flat, but the....
3 Stocks to Buy for the Next Generation
Cutting-edge technology could make ABB Ltd. (NYSE: ABB), Illumina (NASDAQ: ILMN), and TransEnterix (NYSEMKT: TRXC) smart stocks for people to buy and hold for the long haul. Our Motley Fool....
Better Buy: Johnson & Johnson vs. Pfizer
They're two of the oldest, largest, and most respected healthcare companies around. But one has made investors much happier than the other in recent years. Johnson & Johnson (NYSE: JNJ) stock....
Is Pfizer Inc. a Buy?
Pfizer Inc. (NYSE: PFE) shares have risen around 12% this year, in step with the iShares US Pharmaceuticals index. With talk of another spinoff and strong sales growth, this big pharma stock looks....
Ionis Pharmaceuticals Tumbles on Biogen's Miss: Buy or Sell?
Ionis Pharmaceuticals (NASDAQ: IONS) lost 11% of its market value after commercialization partner Biogen (NASDAQ: BIIB) reported third-quarter sales of its drug, Spinraza, that failed to match....
Illumina Inc. Keeps Up Its Winning Ways Thanks to NovaSeq Sales Growth
There was plenty to like when Illumina (NASDAQ: ILMN) reported its second-quarter results in August. Pretty much everything that could go right has gone right for the gene-sequencing leader.....
3 Value Stocks for Retirement
Retirement marks the crowning achievement of a lifetime of hard work and frugal saving. However, it does not mark the end of a marathon, as many believe. It merely marks the beginning of what will....
3 Healthcare Value Stocks
The words "healthcare" and "value" don't seem to go together in the stock market right now as the sector has been hot in 2017, but that's only if you look at traditional valuation metrics and not....
Why Ionis Pharmaceuticals Inc. Slipped This Morning
Shares of Ionis Pharmaceuticals Inc. (NASDAQ: IONS) dipped 13% lower in early morning trading on Tuesday after its most important collaboration partner reported some disturbing third-quarter sales....
Is Regeneron Pharmaceuticals, Inc. Stock a Buy?
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stock has been a huge winner in the past. A $10,000 investment in the biotech 10 years ago would be worth more than $200,000 today. Regeneron's....
In Case You Missed It, Johnson & Johnson Is Undergoing a Major Business Transformation
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a staple stock. It's a common holding for growth, value, and income investors given that many of the products it....
Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their....